Issue 128 • March 2023 Inside the hunt for an Alzheimer’s disease vaccine 4D Molecular’s Fabry gene therapy program on FDA clinical hold Price is key for market adoption of Amgen’s Amjevita In association with ‘Right shoring’ API production in Europe Amidst rising inflation and ongoing drug shortages, is the EU at risk of getting ‘right-shoring’ wrong? In association with 03/02/2023 09:31:13
